5-methylcytidine has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Gu, X; Li, X; Liu, Y; Song, S; Wang, J; Wang, Z; Xu, B; Yang, Q; Yu, G; Zhan, M | 1 |
| Bova, GS; Brooks, JD; Campbell, PA; Epstein, JI; Hsieh, WS; Isaacs, WB; Lee, WH; Morton, RA; Nelson, WG | 1 |
2 other study(ies) available for 5-methylcytidine and Cancer of Prostate
| Article | Year |
|---|---|
Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Topics: Cytidine; Genes, Regulator; Humans; Male; Methylation; Prostatic Neoplasms; RNA; Tumor Microenvironment | 2022 |
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Topics: Carcinoma; Cytidine; DNA Topoisomerases, Type I; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Male; Methylation; Prostate; Prostatic Neoplasms; Regulatory Sequences, Nucleic Acid; Restriction Mapping; RNA, Messenger | 1994 |